News

The National Institutes of Health office responsible for issuing federal guidelines related to treatment of HIV and AIDS patients in the United States plans to phase them out next year.
The National Institutes of Health office responsible for issuing federal guidelines related to treatment of HIV and AIDS patients in the United States plans to phase them out next year.
Strategies that address population-specific concerns about medical mistrust and employ operational tactics, including staff ...
Only 17,000 Ugandans to benefit from $1.1m Global Fund support as officials warn of high demand for long-acting prevention ...
The drug, in June, received FDA approval as the first twice-yearly pre-exposure prophylaxis (PrEP) option to reduce the risk ...
When it comes to a clinical study to evaluate the therapeutic effect of Shivagutika treatment in patients with HIV, it was ...
The National Institutes of Health will phase out its support of the clinical practice guidelines that advise doctors how to diagnose and treat HIV.
Boost your metabolism during menopause! Expert shares actionable tips to enhance your well-being and manage weight gain ...
Millions of Indians are struggling to sleep well, whether due to stress, anxiety or not being able to turn off their phones.
The injectable HIV prevention treatment Yetzugo, made by Gilead Sciences, has received FDA approval, offering a twice-yearly alternative to daily medications.